I. Karakaya et al. / Tetrahedron xxx (2014) 1e4
3
Table 3
127.3, 127.2, 121.8, 69.8, 23.4; HRMS calculated for C16H14N2O:
251.1186. Found: 251.1187.
Enantioselective addition of phenylacetylene to aldehydes using ligand 5a
4.2. (S)-2-Methyl-1-(4-phenylquinazolin-2-yl)propan-1-ol 5b
General procedure
1
was followed using (S)-1-(4-
Entry Aldehyde
Product eea (%) Yieldb (%) Config.c
chloroquinazolin-2-yl)-2-methylpropyl acetate 7b (4.50 g,
16.10 mmol), phenylboronic acid (2.06 g, 16.95 mmol), Pd(PPh3)4
(371 mg, 0.32 mmol) and Na2CO3 (16 mL, 2 M in water) in a solution
in mixture of DME (15 mL) and ethanol (15 mL). The crude product
was purified by column chromatography (hexane-EtOAc, 7:1), and
then crystallised on addition of ethanol to give (S)-2-methyl-1-(4-
1
Benzaldehyde
8a
8b
8c
8d
8e
8f
84
88
75
86
78
83
87
80
97
91
89
91
88
76
53
67
13
89
75
98
73
67
96
95
78
76
98
77
94
85
74
68
70
82
R24
R25
R26
R24
R27
R24
R24
R28
R24
R24
R24
R25
R29
NA
R30
R31
S31
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
2-Methoxybenzaldehyde
3-Methoxybenzaldehyde
4-Methoxybenzaldehyde
2-Chlorobenzaldehyde
3-Chlorobenzaldehyde
4-Chlorobenzaldehyde
3-Bromobenzaldehyde
4-Bromobenzaldehyde
3-Methylbenzaldehyde
4-Methylbenzaldehyde
1-Naphthaldehyde
8g
8h
8i
8j
8k
8l
phenylquinazolin-2-yl)propan-1-ol 5b as
a colourless solid
(4.08 g, 91%). Mp: 69e70 ꢀC; [
a
]
D
ꢁ5.29 (c 1.7, CH2Cl2); ee: 99%;
retention time 5.1 min, Chiralcel OD-H, 90:10 n-hexane-i-PrOH,
flow rate of 1 mL/min, 254 nm; IR (KBr, cmꢁ1) 3455, 3061, 2959,
2928, 1613, 1487, 1143, 1019; 1H NMR (400 MHz, CDCl3, ppm)
d 8.12
Furfural
Crotonaldehyde
Propionaldehyde
Isobutyraldehyde
8m
8n
8o
8p
(d, J¼7.5 Hz, 1H), 8.08 (d, J¼8.4 Hz, 1H), 7.94e7.58 (m, 7H), 4.92 (dd,
J¼5.6, 3.4 Hz, 1H), 4.46 (d, J¼5.6 Hz, 1H), 2.54e2.46 (m, 1H), 1.17 (d,
J¼7.0 Hz), 0.77 (d, J¼6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3, ppm)
d
168.6, 166.1, 150.5, 137.1, 133.9, 130.1, 128.6, 128.4, 127.4, 127.2,
Cyclohexanecarbaldehyde 8r
121.7, 34.0, 19.9, 15.4, 0.02; HRMS calculated for C16H14N2O:
279.1499. Found: 279.1503.
a
Determined by chiral HPLC (Chiralcel OD-H).
Isolated yields.
The absolute configurations of adducts were assigned in accordance with
b
c
literature.
4.3. (S)-2,2-Dimethyl-1-(4-phenylquinazolin-2-yl)propan-1-
ol 5c
cyclohexanecarbaldehyde corresponding adduct accomplished nei-
ther a good enantioselectivity nor the same sense of stereoselectivity.
General procedure
1
was followed using (S)-1-(4-
chloroquinazolin-2-yl)-2,2-dimethylpropyl acetate 7c (2.30 g,
7.85 mmol), phenylboronic acid (1.01 g, 8.24 mmol), Pd(PPh3)4
(180 mg, 0.157 mmol) and Na2CO3 (17.3 mL, 2 M in water) in a so-
lution in mixture of DME (15 mL) and ethanol (15 mL). The crude
product was purified by column chromatography (hexane/EtOAc,
7:1), and then crystallised on addition of ethanol to give (S)-2,2-
dimethyl-1-(4-phenylquinazolin-2-yl)propan-1-ol 5c as a colour-
3. Conclusions
In summary, we successfully prepared novel chiral quinazolinols
(5aee) from commercially available starting materials in a few
steps. Among these ligands, quinazolinol 5a exhibited high catalytic
activity and asymmetric induction in the alkynylation of aldehydes.
It is of note that the best enantioselectivity (75%) of propargylic
alcohols obtained in our earlier report23 is the worst one in this
present work for aromatic aldehydes. Application of these ligands
in other catalytic enantioselective reactions is currently under in-
vestigation in our laboratory.
less solid (1.84 g, 80%). Mp: 101e103 ꢀC; [
a
]
D þ7.08 (c 2.4, CH2Cl2);
ee: 99%; retention time 5.0 min, Chiralcel OD-H, 90:10 n-hexane/i-
PrOH, flow rate of 1 mL/min, 254 nm; IR (KBr, cmꢁ1) 3459, 3062,
2957, 2866, 1614, 1565, 1546, 1487, 1391, 1068; 1H NMR (400 MHz,
CDCl3, ppm)
d
8.15 (d, J¼8.4 Hz,1H), 8.10 (d, J¼8.5 Hz,1H), 7.92e7.58
(m, 7H), 4.73 (d, J¼7.6 Hz,1H), 4.47 (d, J¼7.6 Hz,1H),1.06 (s, 9H); 13
C
NMR (100 MHz, CDCl3, ppm) d 167.4, 165.3, 150.5, 137.1, 133.8, 130.1,
4. Experimental section
130.1, 128.6, 127.3, 127.1, 121.8, 80.9, 30.9, 26.3; HRMS calculated for
16H14N2O: 293.1655. Found: 293.1653.
C
4.1. General procedure 1 for the preparation of (S)-1-(4-
phenylquinazolin-2-yl)ethanol 5a
4.4. (S)-Phenyl(4-phenylquinazolin-2-yl)methanol 5d
General procedure was followed using (S)-(4-
To a solution of (S)-1-(4-chloroquinazolin-2-yl)ethyl acetate 7a
(5.00 g, 19.90 mmol) in DME (15 mL) and ethanol (15 mL) were
added phenylboronic acid (2.55 g, 20.94 mmol), Pd(PPh3)4 (454 mg,
0.39 mmol) and Na2CO3 (22 mL, 2 M in water). The resulting mix-
ture was then refluxed for 12 h, cooled to room temperature and
diluted with dichloromethane (150 mL). The mixture was washed
with water (3ꢂ75 mL). The organic layer was dried over Na2SO4,
and evaporated under reduced pressure. The crude product was
purified by column chromatography (silica gel, hexane/EtOAc, 7:1),
and then crystallised on addition of ethanol to give (S)-1-(4-
phenylquinazolin-2-yl)ethanol 5a as a colourless solid (4.48 g,
1
chloroquinazolin-2-yl)(phenyl)methyl acetate 7d (5.40 g,
17.26 mmol), phenylboronic acid (2.20 g, 18.12 mmol), Pd(PPh3)4
(396 mg, 0.34 mmol) and Na2CO3 (7.8 mL, 2 M in water) in a solu-
tion in mixture of DME (6 mL) and ethanol (6 mL). The crude
product was purified by column chromatography (hexane/EtOAc,
10:1), and then crystallised on addition of ethanol to give (S)-2,2-
dimethyl-1-(4-phenylquinazolin-2-yl)propan-1-ol 5d as a colour-
less solid (4.58 g, 85%). Mp: 102e106 ꢀC; [
ee: 72%; retention time 8.9 min (major), 11.7 min (minor), Chiralcel
OD-H, 90:10 n-hexane/i-PrOH, flow rate of 1 mL/min, 254 nm; IR
(KBr, cmꢁ1) 3423, 3058, 1613, 1565, 1547, 1389, 1058; 1H NMR
a
]
D þ54.33 (c 2.0, CH2Cl2);
90%). Mp: 85e87 ꢀC; [
a
]
þ7.5 (c 3.2, CH2Cl2); ee: 99%; retention
D
time 6.9 min, Chiralcel OD-H, 90:10 n-hexane/i-PrOH, flow rate of
1 mL/min, 254 nm; IR (KBr, cmꢁ1) 3232, 3048, 2978, 2909, 1613,
(400 MHz, CDCl3, ppm)
d
8.19e7.31 (m, 14H), 6.10 (d, J¼6.3 Hz, 1H),
1486, 1132, 1107; 1H NMR (400 MHz, CDCl3, ppm)
d
8.13 (d,
5.29 (d, J¼6.3 Hz, 1H); 13C NMR (100 MHz, CDCl3, ppm)
d 168.9,
J¼8.8 Hz, 1H), 8.09 (d, J¼8.4 Hz, 1H), 7.93e7.57 (m, 7H), 5.17e5.16
165.2, 150.7, 142.5, 136.9, 134.1, 130.2, 130.2, 128.6, 128.5, 128.2,
127.6, 127.5, 127.2, 126.9, 121.9, 75.5; HRMS calculated for
(m, 1H), 4.6 (s, 1H), 1.71 (d, J¼6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3,
ppm)
d
168.9, 167.3, 150.7, 137.0, 134.0, 130.2, 130.0, 128.6, 128.4,
C16H14N2O: 313.1342. Found: 313.1335.